5 results on '"Maley, Warren R."'
Search Results
2. An alternative surgical technique for caval preservation in liver transplantation.
- Author
-
Doria C, Bodzin AS, Frank AM, Maley WR, and Ramirez CB
- Subjects
- Humans, Liver Failure surgery, Liver Transplantation methods, Vena Cava, Inferior surgery
- Abstract
Introduction: The results of orthotopic liver transplantation in patients with end-stage liver disease continue to improve. Refinements in surgical techniques represent an important part of this improvement., Materials and Methods: With the advent of split-liver and living-donor liver transplantation, inferior vena cava (IVC) preservation transitioned from being a potential option to being mandatory for many cases. Preserving the IVC can be a demanding technical maneuver in many liver transplants and several different approaches have been developed. When utilizing IVC preservation, there are several options for implantation of the graft. The piggyback technique, when feasible, is considered safe and provides hemodynamic stability for the recipient., Results and Discussion: In some cases it may be difficult to perform the piggyback technique if intense inflammatory adhesions and severe significant collateral circulation exist between the IVC and the posterior segments of the liver. In these cases, the retro-hepatic dissection can be carried out with a different approach: the infrahepatic vena cava and the confluence of the three hepatic veins can be cross-clamped en-bloc without dissection., Conclusion: This technique broadens the transplant surgeons' armamentarium and can be used in the setting of a very difficult retro-hepatic dissection. It is safe, and allows a shorter anhepatic phase with caval preservation.
- Published
- 2010
- Full Text
- View/download PDF
3. Prolonged waiting times for liver transplantation in obese patients.
- Author
-
Segev DL, Thompson RE, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, and Maley WR
- Subjects
- Body Mass Index, Comorbidity, Diabetes Mellitus epidemiology, Fatty Liver epidemiology, Fatty Liver surgery, Female, Health Services Accessibility, Hepatitis C epidemiology, Hepatitis C surgery, Humans, Liver Failure surgery, Male, Middle Aged, Obesity, Morbid epidemiology, Patient Selection, Regression Analysis, Resource Allocation organization & administration, Tissue and Organ Procurement statistics & numerical data, Liver Failure epidemiology, Liver Transplantation statistics & numerical data, Obesity epidemiology, Tissue and Organ Procurement organization & administration, Waiting Lists
- Abstract
Objective: To quantify the independent association between obesity and access to liver transplantation., Background: Obesity is associated with higher complication rates, longer hospitalization, and worse survival after liver transplantation. Nevertheless, transplantation provides survival benefit to patients with end-stage liver disease, regardless of body mass index (BMI). We hypothesized that, despite survival benefit, providers were reluctant to transplant obese patients because of the inherent difficulty of these cases and their inferior outcomes. Our goal was to quantify the independent association between BMI and waiting time for orthotopic liver transplantation as a surrogate marker for this reluctance., Methods: We studied 29,136 wait-list candidates in the model for end-stage liver disease (MELD) era, categorized as severely obese (BMI 35-40), morbidly obese (BMI 40-60), and reference (BMI 18.5-35). All models were adjusted for factors relevant to the allocation system, factors possibly influencing access to healthcare, and factors biologically related to disease progression and outcomes., Results: The odds of receiving a MELD exception were 30% lower in severely obese and 38% lower in morbidly obese patients. Similarly, the likelihoods of being turned down for an organ were 10% and 16% higher, and the rates of being transplanted were 11% and 29% lower in severely obese and morbidly obese patients, respectively., Conclusions: Current practice seems to indicate a reluctance to transplant obese patients. If indeed as a community we feel that liver allografts should not be distributed to patients with excessive postoperative risk, we should consider expressing this as a formal change to our allocation policy rather than through informal practice patterns.
- Published
- 2008
- Full Text
- View/download PDF
4. Striking Cholestatic Giant Cell Hepatitis Resulting in Fulminant Liver Failure After Garcinia Cambogia Use.
- Author
-
Flerova, Elizaveta, Ambilil, Manju, Civan, Jesse M., Sass, David A., Maley, Warren R., Pulinthanathu, Rajiv, and Huang, Jialing
- Subjects
LIVER failure ,GARCINIA ,HEPATOLENTICULAR degeneration ,HEPATITIS ,AUTOIMMUNE hepatitis ,BREAST ,LIVER regeneration - Abstract
Garcinia cambogia, a weight control herbal, can cause mild liver toxicity with nonspecific histologic changes. Herein, we reported a case of herbal-induced fulminant cholestatic giant cell hepatitis due to garcinia cambogia use. A 65-year-old woman with breast cancer treated 18 years earlier was admitted for obstructive jaundice for 2 weeks. She started using garcinia cambogia 3 months ago for weight loss. Physical exam showed scleral icterus. Serum studies excluded Wilson's disease, systemic infection including COVID-19 (coronavirus disease 2019), autoimmune hepatitis, and metabolic or toxicologic causes. An urgent liver biopsy showed severe giant cell hepatitis in absence of HSV-1/2, cytomegalovirus, HBsAg and HBcAg (immunostain), and EBV (in situ hybridization). Despite supportive therapy, the patient developed grade 2โ3 hepatic encephalopathy and necessitated liver transplant. The explanted liver was markedly atrophy, in which the most striking histologic finding was diffuse distribution of multinucleated giant hepatocytes with syncytial pattern in a background of extensive zone-1 accentuated, geographic, hemorrhagic, confluent hepatocytic necrosis, along with remarkable hepatocytic and canalicular cholestasis. Marked hepatocellular and sinusoidal iron orverload present. The patient recovered uneventfully. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Acute Liver Failure Requiring Liver Transplantation due to Acute Hepatitis A Virus Infection.
- Author
-
Xie, Chencheng, Fenkel, Jonathan M., Halegoua-DeMarzio, Dina L., Civan, Jesse M., Tholey, Danielle M., Herrine, Steven K., Thapar, Manish, Ambelil, Manju, Arastu, Sanaa, Frank, Adam M., Shah, Ashesh P., Glorioso, Jamie M., Ramirez, Carlo G., Bodzin, Adam S., Maley, Warren R., and Sass, David A.
- Subjects
LIVER failure ,VIRAL hepatitis ,HEPATITIS viruses ,VIRUS diseases ,LIVER transplantation ,PULMONARY aspergillosis ,CHRONIC active hepatitis - Abstract
Introduction. Hepatitis A infection (HAV) is generally characterized by an acute icteric illness or may have a subclinical self-limited course, although rarely, can result in fulminant hepatitis and death. In 2019, the City of Philadelphia declared a public health emergency due to an HAV outbreak. We are reporting a series of four cases of acute liver failure (ALF) requiring liver transplantation (LT) due to acute HAV. Methods. Chart review and case descriptions of four patients with acute HAV-related ALF who were expeditiously evaluated, listed as Status 1A, and who underwent LT between August 2019 and October 2019 at Thomas Jefferson University Hospital. Results. All four patients presented with acute hepatocellular jaundice and had a positive HAV IgM, and all other causes of ALF were excluded. All four cases met the American Association for the Study of Liver Diseases (AASLD) criteria for ALF. Three of the four cases met King's College Criteria of poor prognosis for nonacetaminophen-induced ALF. All four patients underwent successful LT and were discharged six to twelve days postoperatively. One patient died of disseminated Aspergillus infection five months after LT, while the others have had excellent clinical outcomes shown by one-year follow-ups. All four explants had remarkably similar histological changes, revealing acute hepatitis with massive necrosis accompanied by a prominent lymphoplasmacytic inflammatory infiltrate and bile ductular proliferation. Conclusion. Although rare, patients presenting with acute HAV need close monitoring as they may rapidly progress to ALF. Early referral to a transplant center afforded timely access to LT and yielded overall good one-year survival. Widespread HAV vaccination for high-risk individuals is an essential strategy for preventing disease and curbing such future outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.